In the News

Baltimore Sun: Maryland prescription drug cost study finds 2 diabetes medicines have ‘affordability challenges’

July 29, 2025Baltimore SunChevall Pryce Excerpt: “During Monday’s meeting, the board took a

In the News

Maryland Matters: State board determines two Type 2 diabetes drugs may be unaffordable

Jardiance, Farxiga are the first drugs to complete PDAB’s cost review process, clearing the way

In the News

Inside Health Policy:Maryland PDAB Votes Farxiga, Jardiance As Unaffordable

July 28, 2025Inside Health PolicyLuke Zarzecki Excerpt: “The Maryland Prescription Drug